Transformers & Rectifiers India Ltd (TRIL): Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:20 pm

Quick Insight

Transformers & Rectifiers India Ltd (TRIL) presents a mixed picture for investors. With a high P/E ratio of 58.9, the stock seems overvalued, especially when considering the industry average. However, the company's robust Return on Equity (ROE) of 23.4% and Return on Capital Employed (ROCE) of 28.0% indicate efficient management of resources. TRIL's operating profit margin (OPM) of 17% is respectable, although its Price-to-Book Value (P/BV) ratio of 12.85x raises concerns about its valuation. Furthermore, the company's healthy Interest Coverage Ratio (ICR) of 7.10x provides a cushion against financial risks. Investors should closely monitor TRIL's growth prospects and market dynamics to make informed decisions amidst this mix of metrics.

Competitors of Transformers & Rectifiers India Ltd (TRIL)

All Competitor Stocks of Transformers & Rectifiers India Ltd (TRIL)

Quarterly Result

Last Updated: August 12, 2025, 2:41 pm

Below is a detailed analysis of the quarterly data for Transformers & Rectifiers India Ltd (TRIL) based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 529.00 Cr.. The value appears to be declining and may need further review. It has decreased from 676.00 Cr. (Mar 2025) to 529.00 Cr., marking a decrease of 147.00 Cr..
• For Expenses, as of Jun 2025, the value is 441.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 545.00 Cr. (Mar 2025) to 441.00 Cr., marking a decrease of 104.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 88.00 Cr.. The value appears to be declining and may need further review. It has decreased from 131.00 Cr. (Mar 2025) to 88.00 Cr., marking a decrease of 43.00 Cr..
• For OPM %, as of Jun 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 19.00% (Mar 2025) to 17.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 10.00 Cr..
• For Interest, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 5.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 90.00 Cr.. The value appears to be declining and may need further review. It has decreased from 119.00 Cr. (Mar 2025) to 90.00 Cr., marking a decrease of 29.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 25.00%, marking an increase of 4.00%.
• For Net Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 94.00 Cr. (Mar 2025) to 67.00 Cr., marking a decrease of 27.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.24. The value appears to be declining and may need further review. It has decreased from 3.14 (Mar 2025) to 2.24, marking a decrease of 0.90.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 12, 2025, 2:41 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

Below is a detailed analysis of the balance sheet data for Transformers & Rectifiers India Ltd (TRIL) based on the most recent figures (Mar 2024) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2024, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2023) to 14.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2024, the value is 540.00 Cr.. The value appears strong and on an upward trend. It has increased from 381.00 Cr. (Mar 2023) to 540.00 Cr., marking an increase of 159.00 Cr..
• For Borrowings, as of Mar 2024, the value is 256.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 330.00 Cr. (Mar 2023) to 256.00 Cr., marking a decrease of 74.00 Cr..
• For Other Liabilities, as of Mar 2024, the value is 360.00 Cr.. The value appears to be improving (decreasing). It has decreased from 463.00 Cr. (Mar 2023) to 360.00 Cr., marking a decrease of 103.00 Cr..
• For Total Liabilities, as of Mar 2024, the value is 1,170.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,187.00 Cr. (Mar 2023) to 1,170.00 Cr., marking a decrease of 17.00 Cr..
• For Fixed Assets, as of Mar 2024, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 153.00 Cr. (Mar 2023) to 144.00 Cr., marking a decrease of 9.00 Cr..
• For CWIP, as of Mar 2024, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2023) to 5.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2024, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2023) to 4.00 Cr., marking an increase of 3.00 Cr..
• For Other Assets, as of Mar 2024, the value is 1,017.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,030.00 Cr. (Mar 2023) to 1,017.00 Cr., marking a decrease of 13.00 Cr..
• For Total Assets, as of Mar 2024, the value is 1,170.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,187.00 Cr. (Mar 2023) to 1,170.00 Cr., marking a decrease of 17.00 Cr..

Notably, the Reserves (540.00 Cr.) exceed the Borrowings (256.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Transformers & Rectifiers India Ltd (TRIL), here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.21. This value is within the healthy range. It has increased from 3.24 (Mar 24) to 7.21, marking an increase of 3.97.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.21. This value is within the healthy range. It has increased from 3.24 (Mar 24) to 7.21, marking an increase of 3.97.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.11. This value is within the healthy range. It has increased from 5.03 (Mar 24) to 8.11, marking an increase of 3.08.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.71. It has increased from 39.49 (Mar 24) to 41.71, marking an increase of 2.22.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.71. It has increased from 39.49 (Mar 24) to 41.71, marking an increase of 2.22.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 67.28. It has decreased from 90.81 (Mar 24) to 67.28, marking a decrease of 23.53.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 11.97. This value is within the healthy range. It has increased from 9.81 (Mar 24) to 11.97, marking an increase of 2.16.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.07. This value is within the healthy range. It has increased from 8.08 (Mar 24) to 11.07, marking an increase of 2.99.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.49. This value is within the healthy range. It has increased from 4.52 (Mar 24) to 9.49, marking an increase of 4.97.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.21. This value is within the healthy range. It has increased from 3.30 (Mar 24) to 7.21, marking an increase of 3.91.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.14. This value is within the healthy range. It has increased from 3.12 (Mar 24) to 7.14, marking an increase of 4.02.
• For PBDIT Margin (%), as of Mar 25, the value is 17.78. This value is within the healthy range. It has increased from 10.80 (Mar 24) to 17.78, marking an increase of 6.98.
• For PBIT Margin (%), as of Mar 25, the value is 16.45. This value is within the healthy range. It has increased from 8.89 (Mar 24) to 16.45, marking an increase of 7.56.
• For PBT Margin (%), as of Mar 25, the value is 14.10. This value is within the healthy range. It has increased from 4.97 (Mar 24) to 14.10, marking an increase of 9.13.
• For Net Profit Margin (%), as of Mar 25, the value is 10.71. This value exceeds the healthy maximum of 10. It has increased from 3.63 (Mar 24) to 10.71, marking an increase of 7.08.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.61. This value is within the healthy range. It has increased from 3.43 (Mar 24) to 10.61, marking an increase of 7.18.
• For Return on Networth / Equity (%), as of Mar 25, the value is 17.11. This value is within the healthy range. It has increased from 8.02 (Mar 24) to 17.11, marking an increase of 9.09.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.00. This value is within the healthy range. It has increased from 18.31 (Mar 24) to 24.00, marking an increase of 5.69.
• For Return On Assets (%), as of Mar 25, the value is 9.80. This value is within the healthy range. It has increased from 3.80 (Mar 24) to 9.80, marking an increase of 6.00.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 24) to 0.06, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.46 (Mar 24) to 0.22, marking a decrease of 0.24.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.20. It has increased from 1.10 (Mar 24) to 1.20, marking an increase of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 1.83 (Mar 24) to 1.74, marking a decrease of 0.09.
• For Quick Ratio (X), as of Mar 25, the value is 1.19. This value is within the healthy range. It has decreased from 1.32 (Mar 24) to 1.19, marking a decrease of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.96. This value is below the healthy minimum of 4. It has increased from 3.28 (Mar 24) to 3.96, marking an increase of 0.68.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 20. It has decreased from 4.46 (Mar 24) to 1.33, marking a decrease of 3.13.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 20. It has decreased from 2.87 (Mar 24) to 1.18, marking a decrease of 1.69.
• For Earning Retention Ratio (%), as of Mar 25, the value is 98.67. This value exceeds the healthy maximum of 70. It has increased from 95.54 (Mar 24) to 98.67, marking an increase of 3.13.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.82. This value exceeds the healthy maximum of 70. It has increased from 97.13 (Mar 24) to 98.82, marking an increase of 1.69.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.10. This value is within the healthy range. It has increased from 2.75 (Mar 24) to 7.10, marking an increase of 4.35.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.21. This value is within the healthy range. It has increased from 1.93 (Mar 24) to 5.21, marking an increase of 3.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 16,218.97. It has increased from 5,879.03 (Mar 24) to 16,218.97, marking an increase of 10,339.94.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.03. This value exceeds the healthy maximum of 3. It has increased from 4.54 (Mar 24) to 8.03, marking an increase of 3.49.
• For EV / EBITDA (X), as of Mar 25, the value is 45.16. This value exceeds the healthy maximum of 15. It has increased from 42.02 (Mar 24) to 45.16, marking an increase of 3.14.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.97. This value exceeds the healthy maximum of 3. It has increased from 4.36 (Mar 24) to 7.97, marking an increase of 3.61.
• For Retention Ratios (%), as of Mar 25, the value is 98.66. This value exceeds the healthy maximum of 70. It has increased from 95.53 (Mar 24) to 98.66, marking an increase of 3.13.
• For Price / BV (X), as of Mar 25, the value is 12.85. This value exceeds the healthy maximum of 3. It has increased from 10.18 (Mar 24) to 12.85, marking an increase of 2.67.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.97. This value exceeds the healthy maximum of 3. It has increased from 4.36 (Mar 24) to 7.97, marking an increase of 3.61.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness